Structure Therapeutics
Chelsea Olsen, PhD, is an experienced professional in the field of medical and regulatory writing. Chelsea's career spans various roles in companies such as Structure Therapeutics, Pfizer, and Global Blood Therapeutics. With a background in Molecular and Cellular Biology, Chelsea has also held positions in antiviral research and development, showcasing their diverse expertise in the healthcare industry.
This person is not in any offices
Structure Therapeutics
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.